The interplay between DNMTi and HDACi also involves intricate signaling networks, such as p53 and IFN pathways, which may be activated by DNA damage or immune stimulation, further enhancing immune cell recruitment and tumor cell death. This evidence concerns the gene TP53 and neoplasm.